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Abstract 
IgM is the first antibody to be produced in a humoral immune response 
and plays an important role in the primary stage of immunity.  Here, we 
describe a mouse Fc receptor, designated Fcα/μ receptor, and its human 
homologue which bind both IgM and IgA with intermediate or high affinity.  
The Fcα/μ receptor is constitutively expressed on the majority of B-
lymphocytes and macrophages.  Cross-linking of Fcα/μ receptors 
expressed on a pro-B cell line Ba/F3 transfectant with soluble IgM or IgM-
coated microparticles induced internalization of the receptor.  Moreover, 
the Fcα/μ receptor mediated endocytosis of Staphylococcus aureus  
coated with IgM by primary B-lymphocytes.  Thus, the Fcα/μ receptor is 
involved in the primary stage of the immune response against microbes.  
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The interaction of antibody-antigen complexes with cells results in a wide array 
of immune responses, including antibody-dependent cellular cytotoxicity, mast 
cell degranulation, phagocytosis, cell proliferation, antibody secretion and 
enhancement of antigen presentation1-3.  These interactions are initiated 
through binding of the Fc portions of antibodies or immune complexes to cell 
surface receptors on hematopoietic cells.  For example, IgG antibodies bind the 
Fcγ receptor on macrophages and neutrophils mediating phagocytosis of 
opsonized microorganisms and/or secretion of cytokines involved in 
inflammation.  IgE antibodies induce the release of chemical mediators from 
mast cells and basophils by binding to the Fcε receptor.  Considerable progress 
has been made in elucidating the structural and functional diversity of the Fc 
receptors for IgG and IgE.  Results obtained in Fc receptor-deficient mice show 
an important role for those receptors on host immunity, allergy or 
autoimmunity4-10.  Analysis of mice lacking the gene for the α subunit of the 
high-affinity IgE receptor, Fcε receptor I, reveals a defect in IgE-triggered 
passive anaphylaxis due to the absence of the Fcε receptor I on mast cells and 
basophils4.  Similarly, mice with a disrupted γ gene from the IgE Fcε receptor I 
or the IgG Fcγ receptor I and III exhibit identical phenotypes5.  Moreover, Fc 
receptor γ gene knockout mice lack IgG-mediated phagocytosis by 
macrophages5 and the ability to mount the Arthus reaction6.  In contrast to 
these triggering Fc receptors, the Fcγ receptor IIb inhibits BCR-triggered 
lymphocyte proliferation, antibody secretion and lymphokine secretion1.  
Antibody and anaphylactic responses to antigen are elevated in mice lacking 
the Fcγ receptor IIb gene7.  
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  Because IgM is the first antibody to be produced in a humoral immune 
response, it may play an important role in the innate stage of immunity.  In 
addition, natural antibodies, involved in the prevention of pathogen 
dissemination to vital organs, are mainly IgM11.  However, it is not known how 
IgM protects against infection.  The existence of functional Fc receptors for IgM 
on subpopulations of human and rodent T, B and NK cells has been 
suggested12-17.  However, by contrast to γ- and ε-Fc receptors, the structural 
and functional characteristics of the Fcμ receptor are unclear because a Fcμ 
receptor gene has not been cloned, although a polymeric Ig receptor able to 
bind IgM and IgA has been described18.  Similarly, although a human Fcα 
receptor (CD89) gene has been characterized19, a homologous rodent Fcα 
receptor has not yet been identified.  In the present investigation, we have 
identified a murine Fc receptor, designated Fcα/μ receptor, and its human 
homologue that binds both IgA and IgM.  We describe the functional and 
molecular characteristics of this receptor.  
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Results  
Characteristics of the mouse and human Fcα/μ receptors 
To identify a Fc receptor for IgM, we screened COS-7 cells transfected with a 
cDNA library prepared from the mouse T cell leukemia, BW5147, by using a 
mouse IgM monoclonal antibody (mAb) as a probe.  We isolated a cDNA clone 
of 2,361 bp that contains an open reading frame encoding a type I 
transmembrane protein with a 32 amino acids (aa) leader sequence, a 423 aa 
extracellular domain, a 20 aa transmembrane domain and a 60 aa cytoplasmic 
region (Fig. 1a).  The extracellular domain has four potential sites for NH2-linked 
glycosylation, suggesting that the receptor is a glycoprotein.  A pair of cysteine 
residues in the extracellular domain is flanked by the consensus sequence for 
Ig-like domains (Fig. 1a, b), indicating that this molecule, designated mFcα/μ 
receptor, is a member of the Ig supergene family.  A human cDNA with 
homology to the mFcα/μ receptor was isolated from a human lymph node cDNA 
library and was found to encode a protein with 49% amino-acid identity to the 
mFcα/μ receptor.  These genes were mapped by fluorescence in-situ 
hybridyzation (FISH)20 to syntenic regions of mouse chromosome 1 (1F) and 
human chromosome 1 (1q32.3), near several other Fc receptors, including Fcγ 
receptors I to III, the Fcε receptor and the polymeric Ig receptor21.  No tyrosines 
are present in the cytoplasmic domain, but there is a di-leucine motif in the 
mFcα/μ receptor that may be involved in receptor internalization.  The Fcα/μ 
receptor is unique, showing no significant homology to other proteins or 
nucleotide sequences in the GenBank, EMBL, or DDBJ databases.  However, 
we observed a motif in the Ig-like domain that is conserved in the first Ig-like 
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domain of human, bovine and rodent polymeric Ig receptors which binds to the 
Fc of IgA and IgM22-24 (Fig. 1b).  Overall, the Fcα/μ receptor has less than 10% 
amino acid homology with the mouse and human polymeric Ig receptor.  
COS-7 cells were transfected with the Flag-tagged  mouse Fcα/μ 
(mFcα/μ) receptor cDNA at the NH2-terminus, which resulted in surface 
expression of the receptor as detected by immunofluorescence using a mAb to 
Flag (anti-Flag)  (data not shown).  Immunoprecipitation of the Flag-tagged 
mFcα/μ receptor on the COS-7 transfectants using anti-Flag revealed an ~70 
kD protein in reducing and non-reducing conditions (Fig. 1c).   
 
Expression of the Fcα/μ receptor 
 To analyze the expression of the mFcα/μ receptor in various tissues we 
used reverse transcription-polymerase chain reaction (RT-PCR).  The mFcα/μ 
receptor is expressed in several tissues, including thymus, spleen, liver, kidney, 
small and large intestines, testis, and placenta (Fig. 2a).  The mFcα/μ receptor 
transcripts were also detected in the T cell leukemia cell lines, RLmale1 and 
BW5147 (data not shown).  To further analyze the expression of the mFcα/μ 
receptor on hematopoietic cells, RNA was obtained from lymphohematopoietic 
progenitor and lineage-committed cells in the bone marrow, thymus and spleen.  
The mFcα/μ receptor transcripts were expressed in B220+ B cells in bone 
marrow and spleen, but not in lymphohematopoietic progenitors, granulocytes, 
T cells or NK cells (Fig. 2b).  To confirm the cell surface expression of the 
mFcα/μ receptor protein, we generated a mAb (rat IgG isotype) to the mFcα/μ 
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receptor.  Analysis of spleen cells by flow cytometry showed that the Fcα/μ 
receptor is expressed on the majority of B cells and macrophages but not on 
granulocytes, T cells or NK cells (Fig. 2c). 
 
The Fcα/μ receptor binds IgM and IgA 
 To determine the binding specificity of this receptor, we established a 
Ba/F3 transfectant stably expressing the mFcα/μ receptor.  Flow cytometric 
analysis showed that the transfectant specifically bound several mouse IgM 
mAbs and both dimeric and monomeric IgA mAbs but not any IgG mAbs tested 
including mouse IgG1, IgG2a, IgG2b and IgG3 (Fig. 3a).  The  mFcα/μ receptor 
transfectant also bound rat IgM and IgA mAbs, and human IgM (data not 
shown).  By contrast, the parental Ba/F3 cells, which do not express the Fcα/μ 
receptor, did not bind any of these mAbs (Fig. 3a).  Moreover, the  Ba/F3 
transfectant bound the Fc, but not F(ab’)2, fragment of human IgM (Fig. 3c). 
Therefore, the Fcα/μ receptor is a specific Fc receptor for the mouse IgM and 
IgA and cross-reacts with human and rat IgM, and rat IgA.  To confirm the 
binding specificity, the Ba/F3 transfectant was pre-incubated with a pure mouse 
IgM or rat IgA mAbs and then stained with a different FITC-conjugated mouse 
or rat IgM mAbs.  Binding of FITC-labeled mouse IgM and IgA mAbs was 
inhibited by pre-incubation of the transfectant with IgM or IgA mAbs (Fig. 3b), 
indicating that the molecule is a specific receptor for IgM and IgA.  Binding of 
IgM and IgA to the mFcα/μ receptors expressed on the Ba/F3 transfectant was 
also determined with 125I-labeled ligands.  The mFcα/μ receptor bound with high 
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affinity any species of IgM tested.  In addition, the mFcα/μ receptor also bound 
mouse IgA with intermediate affinity (Fig. 3d).  
 
The Fcα/μ receptor and endocytosis of IgM-coated beads 
 The cytoplasmic domain of the mFcα/μ receptor contains a di-leucine 
motif (Fig. 1a), implicated in endosome and lysosome targeting of diverse 
proteins and involved in agonist-induced internalization25-28.  A di-leucine motif 
is involved in Fcγ receptor IIB-mediated endocytosis3, 29.  To investigate whether 
the Fcα/μ receptor internalizes upon cross-linking, the Ba/F3 transfectants 
expressing the Fcα/μ receptor were incubated with FITC-labeled mouse IgM 
and then cross-linked with goat anti-mouse IgM at 4oC or 37 oC for 1 h.  Some 
of the transfectants were treated with trypsin to remove the FITC-labeled mouse 
IgM bound to the cell surface Fcα/μ receptors that did not undergo 
internalization.  Treatment with trypsin significantly decreased the fluorescence 
intensity of the transfectant expressing the Fcα/μ receptor which was incubated 
at 4oC after cross-linking (Fig. 4a).  By contrast, the fluorescence remained 
constant in the transfectant which was incubated at 37oC after cross-linking, 
despite treatment with trypsin. This suggests that cross-linking the Fcα/μ 
receptor with IgM induced internalization of the Fcα/μ receptor during culture at 
37oC.   
 We next examined whether the Fcα/μ receptor is involved in endocytosis. 
Ba/F3 transfectants expressing the mFcα/μ receptor were incubated with IgM-
coated fluorescent beads at 37oC.  After extensive washing and treatment with 
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trypsin, we analyzed the cells by flow cytometry. A  subpopulation of the Ba/F3 
transfectants containing fluorescent beads was detected (Fig. 4b).  The 
fluorescent beads were also seen in the cytoplasm of the transfectant using 
immunofluorescent microscopy and confocal scanning laser microscopy (Fig. 
4c-e), indicating that the Fcα/μ receptor is involved in endocytosis of IgM-
coated beads.  Transfectants incubated with fluorescent beads not coated with 
IgM were not engulfed by the transfectants (data not shown). 
 
The di-leucine motif of the Fcα/μ receptor  
We examined whether the di-leucine motif at residues 519 and 520 in 
the cytoplasmic portion of the mFcα/μ receptor is involved in the internalization 
of the Fcα/μ receptor.  We made Ba/F3 transfectants stably expressing 
Fcα/μ receptors mutated at residue 519, 520 or both and incubated them with 
IgM-coated green fluorescent beads at 37oC.  The fluorescent beads were not 
detected in any of the Ba/F3 transfectants expressing mutant Fcα/μ receptors 
(Fig. 4b). These results indicate that both leucines at residue 519 and 520 are 
required for internalization by the mFcα/μ receptor.  Several other Fc receptors, 
including FcγRI, FcγRIIIA, FcεRI, and FcαRI, also mediate endocytosis30-33 that 
is dependent on the associated subunit Fc receptor γ chain34. We did not 
observe an association of the Fcα/μ receptor with the γ chain.  Because the 
human Fcα/μ receptor does not have a di-leucine motif in its cytoplasmic 
domain; other elements in the human receptor probably serve this function.   
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The Fcα/μ receptor mediates endocytosis by primary B-lymphocytes 
To examine the biological significance of the Fcα/μ receptor-mediated 
endocytosis, mouse spleen cells were incubated with immune complexes 
composed of FITC-labeled S. aureus bacteria coated with IgM or IgG antibodies 
toS. aureus.  After overnight culture, the cells were treated with trypsin, stained 
with PE-conjugated anti-B220 mAb and analyzed by flow cytometry.  While 
B220+ spleen cells cultured with the IgG S. aureus immune complex did not 
show any specific green fluorescence, a subset of B220+ cells cultured with 
theS. Aureus IgM immune complex showed detectable levels of fluorescence. 
When spleen cells were precoated with rat anti-mFcα/μ receptor mAb and 
incubated with the IgM-S. aureus complex, B220+ cells did not show any 
specific fluorescence (Fig. 4f).  The B220+ B cells incubated with the IgM-S. 
aureus complexes were isolated by flow cytometry and examined by 
fluorescence microscopy.  These cells contained one or more FITC-labeled S. 
aureus bacteria in the cytoplasm (Fig. 4g,h).  These results indicate that the 
mFcα/μ receptor mediates endocytosis of IgM-coated microbial pathogens.  
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Discussion 
  Prior reports suggested the existence of functional Fc receptors for IgM 
on murine and human T, B and NK cells12-17.  However, functional and 
molecular characteristics of these Fcμ receptors have remained elusive.  
Among them, a human Fcμ receptor, which is expressed on activated B cells, 
but not on macrophages, is a ~60 kD glycosyl phosphatidylinositol (GPI) -linked 
protein15.  The Fcα/μ receptor we describe here is ~70 kD and a 
transmembrane type of glycoprotein expressed on both B cells and 
macrophages.  These data suggest that these Fc receptors are different.  The 
localization of the Fcα/μ receptor gene on chromosome 1 suggested that the 
Fcα/μ receptor may be evolutionary related to Fcγ receptors, the Fcε receptor 
and the polymeric Ig receptor, but distinct from the human Fcα receptor (CD89) 
whose gene is mapped to chromosome 1921.  
We have shown that the Fcα/μ receptor is expressed not only on 
hematopoietic cells but also on variable non-hematopoietic organs, including 
liver, kidney, small and large intestines, testis and placenta.  Although the 
polymeric Ig receptor, which also binds IgM and IgA, is expressed on epithelial 
cells, it is unclear whether the Fcα/μ receptor is expressed on epithelial cells or 
on infiltrated hematopoietic cells in these organs.  Similarly, although purified 
thymic T lymphocytes are deficient in the expression of the Fcα/μ receptor, 
thymic tissue is positive for Fcα/μ receptor expression.   
Nonetheless, we have demonstrated the functional expression of the 
Fcα/μ receptor on B lymphocytes.  Transfection of Ba/F3 cells with the 
Fcα/μ receptor allowed these pro-B cells to engulf IgM-coated particles.  
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Moreover, primary B-lymphocytes uptake IgM-coated microbial pathogens, such 
as S. aureus, through the Fcα/μ receptor, showing the physiological relevance 
of this receptor.  These results suggest at least two kind of the Fcα/μ receptor-
mediated immune responses.  The Fcα/μ receptor may be involved in the 
protection of bacterial infections by allowing phagocytosis of IgM-coated 
organisms and in facilitating of the subsequent antigen processing and 
presentation to helper T lymphocytes.  Reports have demonstrated that mice 
deficient in the secretory form of IgM exhibit delayed development of specific 
IgG antibodies to T cell-dependent foreign antigens35 and dissemination of 
micropathogens in peripheral organs but not in secondary lymphoid organs11.  
These reports suggest that uptake of IgM-antigen immune complexes by B-
lymphocytes and macrophages through the Fcα/μ receptor may play an 
essential role in the priming of helper T lymphocytes.  Analysis of mice lacking 
the Fcα/μ receptor gene will help to analyze the physiological role of this 
receptor. 
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Methods 
Antibodies  
 For binding assays, anti-human CD18 mAb (L130, mouse IgG1), anti-
human CD3 mAb (UCTH1, mouse IgG1), anti- human CD45 mAb (H130, 
mouse IgG1), anti-human CD71 mAb (M-A712, mouse IgG2a), anti-human 
CD11c mAb (LeuM5, mouse IgG2b), anti-human CD2 mAb (Leu5b, mouse 
IgG2b), anti-human CD52 mAb (DX8, mouse IgG3), anti-human CD57 mAb 
(Leu7, mouse IgM), DX18 mAb (mouse IgM), M18-254 mAb (mouse IgA), DX5 
mAb (rat Ig M), TX2 mAb (rat IgM), TX1 mAb (rat IgA), human IgM (obtained 
from a patient with macroglobulinemia, a gift from Dr. Takachika Azuma 
(Science Univ. of Tokyo, Japan), and human IgM Fc fragment (Rockland) were 
used.  Anti-human CD3, anti-human CD45, anti-human CD71 and M18-254 
mAbs were purchased from PharMingen (San Diego, CA). DX5, DX8, DX18, 
TX1 and TX2 mAbs were generated in our laboratories.  For flow cytometric 
analysis and sorting of the spleen, bone marrow and thymus, control IgG, anti-
mouse TCRαβ, anti-mouse CD45R/B220, anti-mouse CD11b (Mac1) mAbs, 
anti-mouse Sca-1, anti-mouse c-kit, anti-Ly6G (Gr-1), TER119, anti-mouse 
CD90 (Thy-1), anti-NK1.1, anti-mouse CD4 and anti-mouse CD8 were used 
(PharMingen).  An anti-mouse Fcα/μ receptor mAb (TX6) was generated by 
fusing the Sp2/0 myeloma cell line with splenocytes from a rat immunized with 
Ba/F3 transfectants expressing the mouse Fcα/μ36.  
 
Reverse transcription- polymerase chain reaction (RT-PCR) 
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 RNA was subjected to reverse transcription and PCR using 
Fcα/μ receptor-specific primers (5'-AGTGTTACCACGAGTGAAGG-3' and 5'-
TTCCATCATCAGGGTCTTGG-3’) or GAPDH-specific primers (5'-
TGCACCACCAACTGCTTAG-3' and 5'-GGATGC AGGGATGATGTTC-3').  
Amounts of cDNA were measured by using an ABI7700 analytical thermal 
cycler (Perkin-Elmer Applied Biosystem, Foster City, CA).  TaqMan Rodent 
GAPDH Control Reagent (Perkin-Elmer Applied Biosystem) was used to 
standardize results.  Conditions used for PCR were: 40 cycles of 20 sec 
denaturation (94oC), 20 sec annealing (55oC), and 20 sec extension (72oC). 
 
Establishment of Ba/F3 transfectants  
 The Fcα/μ receptor cDNA was subcloned into the pMX-NEO retroviral 
vector (kindly provided from Toshio Kitamura, DNAX) using the Eco RI (5’) and 
Not I (3’) cloning sites. To generate site-directed mFcα/μ receptor mutants at 
residues L519 and/or L520, PCR primers, which contained a codon for A 519 
(GCT) and /or A520 (GCT) instead of L519 (CTT) and L520 (CTT), respectively, 
were designed.  The PCR products were subcloned into the pMX-NEO vector.  
All mutant cDNAs were verified by sequencing.  Ba/F3 cells stably expressing 
wild type or mutant Fcα/μ receptors were established37.  
 
Scatchard Analysis 
Antibodies were labeled by chloramine-T-catalyzed iodination and 
purified by gel-filtration chromatography on a PD-10 column (Sephadex G-25 
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M) (Pharmacia Biotech).  Binding of Ba/F3 transfectants with 125 I -labeled 
antibodies and scatchard analysis were performed17. 
. 
Internalization Assay 
 Ba/F3 cells expressing the Fcα/μ receptor were stained with FITC-
labeled mouse IgM (DX18 mAb), followed by cross-linking with goat anti-mouse 
IgM (Pharmingen) at 4oC or 37 oC for 1 h.  Some cells were treated with 0.1% 
trypsin and analyzed by flow cytometry.  For internalization of IgM-coated 
beads, Ba/F3 cells expressing the wild type or mutant Fcα/μ receptor were 
incubated at 37oC for overnight with yellow-green fluorescent beads 
(FluoSpheres Fluorescent Microspheres, 0.5 μm sized in diameter, Molecular 
Probes, Eugene, Oregon), which had been conjugated with mouse IgM (DX18 
mAb) by as per manufacturers instructors.  The cells were then washed with 
PBS and treated with 0.1 % trypsin to remove beads bound to the cell surface.  
The cells were centrifuged onto microscope slides, rapidly air-dried, and then 
analyzed using fluorescent and confocal scanning laser microscopes.  To 
analyze endocytosis of the immune complexes, green fluorescent S. aureus 
(Molecular Probe) were incubated with either medium alone, anti-S. aureus 
mouse IgM or IgG mAbs (QED Bioscience Inc.).  The S. aureus were then 
incubated overnight with spleen cells from C57Bl/6 mice pretreated with anti-
mouse FcγRIII/II mAb (Pharmingen) to block interactions with Fcγ receptors. In 
some experiments, the anti-Fcα/μ receptor mAb (TX6) was also used to block 
the interaction with the Fcα/μ receptor.  The spleen cells were then treated with 
0.1% trypsin, stained with PE-conjugated anti-B220 mAb and analyzed by flow 
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cytometry. B220+ B lymphocytes expressing green fluorescence were sorted, 
cytospinned onto slides and analyzed by using a fluorescent microscope. 
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Figure Legends 
Figure 1. Molecular and biochemical characterization of Fcα/μ receptors. 
(a) Predicted amino acid sequences of human and mouse Fcα/μ receptors. The 
putative leader and transmembrane domain are underlined. The predicted 
binding site for IgA and IgM is boxed. Potential NH2-linked glycosylation sites in 
the extracellular domain are outlined. The arrowheads indicate potential 
cysteine residues involved in disulfide bonding of the Ig-like domains.  A di-
leucine motif in the cytoplasmic portion is shown in bold letters. The cDNA 
sequence data is available from EMBL/GenBank/DDBJ under accession 
number E15470 (human) and AB048834 (mouse).  (b) Comparison of the amino 
acid sequences of the predicted binding sites for IgA and IgM of the Fcα/μ 
receptors and the polymeric Ig receptors.  (c) The mFcα/μ receptor was 
immunoprecipitated with anti-Flag from COS-7 cells transfected with a cDNA 
encoding the Fcα/μ receptor tagged with Flag at the NH2-terminus.  Precipitates 
were analyzed under reducing and non-reducing conditions.  
 
Figure 2.  Expression of the mFcα/μ receptor.  (a, b) Analysis of mFcα/μ 
receptor expression by RT-PCR. cDNA, adjusted to comparable quantities 
using a GAPDH control, were prepared from tissues or cells, as indicated.   
These cDNA or water (used as a negative control) were used as templates for 
RT-PCR.  (c) Analysis of mFcα/μ receptor expression on mouse spleen and 
peripheral blood cells by flow cytometry.  Spleen cells or peripheral blood cells 
from C57/BL6 mice were stained with biotin-conjugated anti-mouse Fcα/μ 
receptor (TX-6 mAb) and the FITC-conjugated mAbs indicated, followed by 
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allophycocyanin (APC)-conjugated streptavidin.  An electronic gate, based on 
characteristic light scattering profiles, was set on mononuclear cells, 
lymphocytes and granulocytes. Greater than 99% of spleen and peripheral 
blood cells stained with control Igs were present in the lower left quadrant of the 
contour plots (data not shown).  Data are representative of several independent 
experiments. 
 
Figure 3.  Binding of immunoglobulins to the mFcα/μ receptor.  (a) Ba/F3 
cells or a Ba/F3 transfectants expressing the mFcα/μ receptor were incubated 
with several FITC-labeled mouse immunoglobulins, as indicated, and analyzed 
by flow cytometry.   (B) The Ba/F3 transfectants expressing the mFcα/μ 
receptor were pre-treated or not with an unconjugated mouse IgM (Leu7 mAb) 
or a rat IgA (TX1 mAb) and then stained with an FITC-labeled mouse IgM 
(DX18 mAb) or an FITC-labeled mouse IgA (M18-254 mAb).  Controls are 
autofluorescence of the cells.  Data are representative of several independent 
experiments.  (c)  The Ba/F3 transfectants expressing the mFcα/μ receptor 
were incubated with FITC-labeled intact human IgM and F(ab’)2 and Fc 
fragment of human IgM, as indicated, and analyzed by flow cytometry.  (d) 
Ligand binding assays.  Ba/F3 transfectants expressing the mFcα/μ receptor 
were incubated with I125-labeled mouse IgM (DX18 mAb), mouse IgA (M18-254 
mAb), rat IgM (DX5 mAb) or human IgM for 2 h on ice, washed four times, and 
the cell-bound radioactivity was determined by using a gamma counter.  Values 
for nonspecific binding, determined by binding to untransfected Ba/F3 cells, 
were subtracted. Data are plotted as Scatchard analyses and are representative 
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of several independent experiments. 
 
Figure 4. Internalization of the mFcα/μ receptor.  (a) The Ba/F3 transfectants 
expressing the mFcα/μ receptor were incubated with FITC-labeled mouse IgM 
(DX18 mAb) at 4oC for 30 min, followed by cross-linking with goat anti-mouse 
IgM at 4oC or 37oC for 1 h.  The cells were treated (+) or not (-) with 0.1% 
trypsin and analyzed by flow cytometry.  The dotted line indicates the 
autofluorescence of the cells.  (b-e) The Ba/F3 transfectants expressing wild 
type (WT) or site-directed mutant mFcα/μ receptors were incubated with FITC-
conjugated mouse IgM (DX18 mAb) for 30 min and analyzed by flow cytometry 
(b, upper panel). The Ba/F3 transfectants were incubated overnight at 37oC 
with mouse IgM (DX18 mAb)-coated green fluorescent beads, treated with 0.1% 
trypsin and analyzed by flow cytometry (b, lower panel), by fluorescent 
microscopy with light (c) or dark field illumination (d), or by confocal scanning 
laser microscopy (e).  Whereas Ba/F3 transfectants bind comparable amounts 
of IgM to the cell surface (b, upper panel), the IgM-coated green fluorescent 
beads were only detected in the cytoplasm of transfectants expressing the wild 
type mFcα/μ receptor (b, lower panel, c-e).  (f-h) FITC-labelled S. aureus were 
incubated with either mediun alone, anti-S. aureus mouse IgM or IgG mAbs. 
The S. aureus were then incubated overnight  at 37oC with mouse spleen cells 
pretreated with anti-mouse FcγRIII/II to block binding to Fc receptors for IgG.  
The spleen cells were then treated with 0.1% trypsin, stained with PE-
conjugated anti-B220 mAb and analyzed by flow cytometry. Data are shown in 
the histogram gated for the B220+ B cell population (f). B220+ B lymphocytes 
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expressing green fluorescence were sorted and analyzed by using fluorescent 
microscopy under light (g) or dark field illumination (h).  Overlapped pictures 
with green- and red-fluorescence are shown (h). 
 
 
 
 
 
